Olema Pharmaceuticals, Inc.
OLMA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $839,318 | $364,219 | $321,203 | $342,475 |
| - Cash | $35,260 | $52,473 | $50,640 | $139,480 |
| + Debt | $1,478 | $1,755 | $1,148 | $1,429 |
| Enterprise Value | $805,536 | $313,501 | $271,711 | $204,424 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$42,174 | -$47,732 | -$34,745 | -$36,652 |
| % Margin | – | – | – | – |
| Net Income | -$42,217 | -$43,784 | -$30,389 | -$33,567 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.49 | -0.51 | -0.36 | -0.57 |
| % Growth | 3.9% | -41.7% | 36.8% | – |
| Operating Cash Flow | -$34,527 | -$29,883 | -$43,979 | -$26,284 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$34,527 | -$29,883 | -$43,979 | -$26,284 |